Abiopharma

🔍 Qian LinLin (Director)

Company: Health In Tech, Inc. (HIT)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 28,183 shares of Class A Common Stock at $1.06 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 8,998,392.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.
• F2: Includes 938,743 restricted shares of Class A Common Stock and 8,059,649 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.